Related Experiment Video
Updated: Aug 15, 2026

11:29
Cost-effective Method for Microbial Source Tracking Using Specific Human and Animal Viruses
Published on: December 3, 2011
Quantitative nested PCR for human cytomegalovirus DNA: analysis using NucleoScan 2001
1Department of Medical Microbiology, St George's Hospital Medical School, London, UK.
The New Microbiologica
|February 24, 2001
Summary
This study developed a sensitive quantitative nested DNA PCR for human cytomegalovirus (CMV). The new method accurately measures CMV DNA in white blood cells, improving detection sensitivity.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Human cytomegalovirus (CMV) is a common pathogen with significant clinical implications.
- Accurate quantification of CMV DNA is crucial for disease management and treatment monitoring.
- Existing PCR methods may lack the sensitivity required for early or low-level viral detection.
Purpose of the Study:
- To develop a highly sensitive quantitative nested DNA PCR assay for human cytomegalovirus (CMV).
- To establish an internal standard using PCR mimic DNA for improved assay accuracy.
- To enhance detection sensitivity for CMV DNA in clinical samples.
Main Methods:
- Development of a quantitative nested DNA PCR assay.
- Utilized PCR mimic DNA as an internal standard for quantification.
- Employed ultra-thin gel electrophoresis and enhanced ethidium bromide staining for detection.
Main Results:
- Achieved a 25-fold increase in sensitivity compared to conventional gel electrophoresis.
- The assay can detect as little as 0.1 ng of DNA per band.
- Successfully quantified CMV DNA in positive leukocyte preparations, detecting single to hundreds of CMV DNA copies per 0.1 μg of total DNA.
Conclusions:
- The developed quantitative nested DNA PCR offers enhanced sensitivity and accuracy for human cytomegalovirus detection.
- This assay is suitable for measuring CMV viral load in leukocyte DNA preparations.
- The improved sensitivity facilitates precise monitoring of CMV DNA levels in clinical settings.

